Phentermine and Nucynta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Phentermine (phentermine hydrochloride) and Nucynta (tapentadol hydrochloride). Common drug interactions include sinusitis among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Phentermine and Nucynta. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Phentermine?

Phentermine has active ingredients of phentermine hydrochloride. It is often used in weight loss. eHealthMe is studying from 19,870 Phentermine users. Check the latest studies of Phentermine.

What is Nucynta?

Nucynta has active ingredients of tapentadol hydrochloride. It is often used in pain. eHealthMe is studying from 31,818 Nucynta users. Check the latest studies of Nucynta.



On Jul, 14, 2026

28 people who take Phentermine and Nucynta together, and have interactions are studied.

Phentermine and Nucynta drug interactions.

What are the common drug interactions of Phentermine and Nucynta, by gender? *:

female:

  1. Sinusitis (inflammation of sinus)
  2. Chronic kidney disease
  3. Headache (pain in head)
  4. Unresponsive to stimuli
  5. Acute myocardial infarction (acute heart attack)
  6. Adrenal adenoma (benign tumour of the glandular type (adenoma) in the adrenal gland)
  7. Asthma
  8. Basedow's disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones)
  9. Bipolar i disorder (mood disorder that is characterized by at least one manic or mixed episode)
  10. Blood potassium decreased

male:

  1. Chronic kidney disease
  2. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  3. Dizziness
  4. Fatigue (feeling of tiredness)
  5. Hallucination (an experience involving the perception of something not present)
  6. Herpes zoster
  7. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  8. Insomnia (sleeplessness)
  9. Vomiting

What are the common drug interactions of Phentermine and Nucynta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Overdose
  2. Unresponsive to stimuli

20-29:

n/a

30-39:

  1. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  2. Dizziness
  3. Hallucination (an experience involving the perception of something not present)
  4. Suicide attempt
  5. Unresponsive to stimuli
  6. Vomiting

40-49:

  1. Cardiac failure congestive
  2. Chest pain
  3. Chronic kidney disease
  4. Congestive cardiomyopathy (weakening of heart muscle)
  5. Fall
  6. Headache (pain in head)
  7. Hunger
  8. Renal failure (kidney dysfunction)
  9. Renal impairment (severely reduced kidney function)
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

50-59:

  1. Chronic kidney disease
  2. Fatigue (feeling of tiredness)
  3. Herpes zoster
  4. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  5. Papillary thyroid cancer
  6. Thyroid mass

60+:

  1. Chronic kidney disease
  2. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  3. Nephrogenic anaemia (anaemia due to kidney disease)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 35.71%
  2. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 21.43%
  3. Infection: 5 people, 17.86%
  4. High Blood Cholesterol: 5 people, 17.86%
  5. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 17.86%
  6. Rickets (softening of bones): 3 people, 10.71%
  7. Pulmonary Congestion (congestion in the lungs): 3 people, 10.71%
  8. Hypertensive Crisis: 3 people, 10.71%
  9. High Blood Pressure: 3 people, 10.71%
  10. Constipation: 3 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Phentermine and Nucynta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Phentermine and Nucynta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Phentermine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nucynta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phentermine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nucynta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on phentermine hydrochloride and tapentadol hydrochloride (the active ingredients of Phentermine and Nucynta, respectively), and Phentermine and Nucynta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: